Related Experiment Video
Updated: Mar 25, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Clostridium difficile ileitis in a patient, after total colectomy.
Aneta Tarasiuk-Rusek1, Kairav J Shah2
1Division of Infectious Diseases and Global Medicine, University of Florida, Gainesville, Florida, USA.
A post-colectomy patient experienced Clostridium difficile infection (CDI) symptoms including diarrhea and fever. Prompt treatment with vancomycin and flagyl led to symptom resolution and discharge.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Colorectal Surgery
Background:
- Clostridium difficile infection (CDI) is a significant cause of infectious diarrhea, particularly in post-surgical patients.
- Total colectomy increases the risk of altered gut microbiota and susceptibility to enteric infections.
- Early recognition and management of CDI are crucial for patient outcomes.
Observation:
- A 63-year-old patient, status post total colectomy, presented with watery diarrhea, abdominal cramping, and fever.
- Abdominal CT revealed diffuse small bowel thickening and mesenteric edema, indicative of infectious enteritis.
- Clostridium difficile PCR testing confirmed the presence of infection.
Findings:
- The patient received oral vancomycin and intravenous metronidazole (flagyl).
- Initial management included bowel rest and nasogastric (NG) tube placement due to ileus.
- Symptoms resolved within 7 days, leading to successful hospital discharge.
Implications:
- This case highlights the importance of considering CDI in post-colectomy patients presenting with gastrointestinal symptoms.
- Appropriate antibiotic therapy and supportive care can effectively manage CDI in this high-risk population.
- Multidisciplinary collaboration, including surgical consultation, is valuable in complex cases.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Constipation-Predominant IBS

